139 related articles for article (PubMed ID: 27158388)
1. The regulation of sGC on the rat model of neuropathic pain is mediated by 5-HT1ARs and NO/cGMP pathway.
Xu Z; Yang B; Zhang J; Zheng J
Am J Transl Res; 2016; 8(2):1027-36. PubMed ID: 27158388
[TBL] [Abstract][Full Text] [Related]
2. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
Xu H; Yue C; Chen L
J Alzheimers Dis; 2019; 71(4):1331-1338. PubMed ID: 31524174
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
4. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
5. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
6. [Role of sGC-cGMP pathway in CO-mediated regulation of respiratory rhythm].
Zhang QL; Yang WX; Zhou H; Sun XC; Shi YJ; Chen Q; Zheng Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):595-8. PubMed ID: 17718419
[TBL] [Abstract][Full Text] [Related]
7. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice.
Tanabe M; Nagatani Y; Saitoh K; Takasu K; Ono H
Neuropharmacology; 2009 Mar; 56(3):702-8. PubMed ID: 19111753
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional roles of guanylate cyclase isoforms in BRIN-BD11 β-cells.
Russell MA; Morgan NG
Islets; 2010; 2(6):374-82. PubMed ID: 21099339
[TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide decreases soluble guanylate cyclase levels by activating the proteasome pathway.
de Frutos S; Saura M; Rivero-Vilches FJ; Rodriguez-Puyol D; Rodriguez-Puyol M
Biochim Biophys Acta; 2003 Dec; 1643(1-3):105-12. PubMed ID: 14654233
[TBL] [Abstract][Full Text] [Related]
12. The NO-cGMP-PKG signal transduction pathway is involved in the analgesic effect of early hyperbaric oxygen treatment of neuropathic pain.
Ding Y; Yao P; Hong T; Han Z; Zhao B; Chen W
J Headache Pain; 2017 Dec; 18(1):51. PubMed ID: 28470432
[TBL] [Abstract][Full Text] [Related]
13. [Electroacupuncture relieved neuropathic pain by suppressing L-Arg/NO/cGMP pathway in the lumbar spinal cord in rats with spared nerve injury].
Yan LP; Hou BQ; Li SD; Wang LL; Ma C
Zhen Ci Yan Jiu; 2019 Dec; 44(12):893-7. PubMed ID: 31867909
[TBL] [Abstract][Full Text] [Related]
14. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors.
Xu L; Mabuchi T; Katano T; Matsumura S; Okuda-Ashitaka E; Sakimura K; Mishina M; Ito S
Nitric Oxide; 2007 Aug; 17(1):18-24. PubMed ID: 17548218
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neuronal nitric oxide release by soluble guanylyl cyclase in guinea pig colon.
Hallén K; Olgart C; Gustafsson LE; Wiklund NP
Biochem Biophys Res Commun; 2001 Feb; 280(4):1130-4. PubMed ID: 11162644
[TBL] [Abstract][Full Text] [Related]
18. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylyl cyclase is localised in the acinar cells and participates in amylase secretion in rat parotid gland.
Shimomura H; Tanaka S; Komine N; Shimooka S; Imai A; Nashida T
Arch Oral Biol; 2004 Sep; 49(9):691-6. PubMed ID: 15275856
[TBL] [Abstract][Full Text] [Related]
20. Effect of zaprinast on nitric oxide levels in serum and aortic tissue.
Ibrahim MA; Asai H; Satoh S; Satoh N; Ueda S
Methods Find Exp Clin Pharmacol; 2004; 26(1):19-24. PubMed ID: 14988737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
